Tech Company Financing Transactions

1910 Genetics Funding Round

M12, Playground Global and private investors participated in a $22 million Series A venture round for 1910 Genetics. This VC investment round was announced on 3/25/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

700 Main St.
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.1910genetics.com

Email Address

[email protected]

Overview

1910 Genetics is unique in its capability to apply AI to the design of both small molecule and protein therapeutics. ELVIS� is 1910 Genetics' small molecule drug discovery engine, which consists of three AI platforms and one biological assay platform.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jen Nwankwo

        

Vice President

Lewis Whitehead

        

Browse more venture capital transactions:

Prev: 3/25/2021: Scribe Therapeutics venture capital transaction
Next: 3/25/2021: Asher Bio venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary